What is Qualis Innovations Operating Cash Flow per Share?
Qualis Innovations's operating cash flow per share for the
three
months ended in Mar. 2024 was $-0.00.
Qualis Innovations's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.00.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 95.90% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 94.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Qualis Innovations's Operating Cash Flow per Share or its related term are showing as below:
QLIS'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 76.6 Med: 95.6 Max: 96.7
Current: 95.9
During the past 9 years, Qualis Innovations's highest 3-Year average Operating Cash Flow per Share Growth Rate was 96.70% per year. The lowest was 76.60% per year. And the median was 95.60% per year.
QLIS's 3-Year OCF Growth Rate is ranked better than 98.26% of 688
companies
in the Medical Devices & Instruments industry
Industry Median: 2.55
vs QLIS: 95.90
Qualis Innovations Operating Cash Flow per Share Historical Data
The historical data trend for Qualis Innovations's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Qualis Innovations Operating Cash Flow per Share Chart
Competitive Comparison of Qualis Innovations's Operating Cash Flow per Share
For the Medical Devices subindustry, Qualis Innovations's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qualis Innovations's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Qualis Innovations's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Qualis Innovations's Price-to-Operating-Cash-Flow falls into.
Qualis Innovations Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Qualis Innovations's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qualis Innovations Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Qualis Innovations's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Qualis Innovations (Qualis Innovations) Business Description
Qualis Innovations Inc. is the holding company of mPathix Health, Inc. The company is focused on the development, production, and distribution of multi-modal pain management and Central Nervous System related solutions. It develops pain management products using a modality agnostic, virtual operating model. The company is developing a product designed to address the unmet needs of patients who seek alternatives to traditional pain medications and interventions or adjunctive therapies to their current treatment regimen.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
QLIS has been successfully added to your 